Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Soft glove helps stroke survivors regain hand function

NCT ID NCT07327151

Symptom relief Sponsor: Kocaeli University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a soft rehabilitation glove could improve hand movement and daily activities in people who had a stroke more than three months ago. Thirty-four participants used the glove for 20 minutes a day, five days a week, for three weeks, alongside standard therapy. The glove helps with finger movements, grasping, and tasks like eating and brushing hair. The goal was to see if it makes daily life easier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
soft rehabilitation glove (Sybero SRG)
What this could lead to
If effective, this glove could become a simple, low-cost tool to help stroke survivors regain hand movement and independence in daily tasks.
What could go wrong
This is a small, completed trial with only 34 participants. Results may not apply to all stroke survivors, and the device is not yet widely available or proven in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Feb 2024

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Individuals aged 18 and above who have experienced cerebrovascular events confirmed by neuroimaging and are planned to be enrolled in a neurological rehabilitation treatment program. 2. Those whose event date was more than 3 (three) months. 3. Individuals with upper limb and hand assessment of 3 or above according to the Brunnstrom Motor Assessment Scale. 4. Those with spasticity level of 2 and below in upper limb muscle groups according the Modified Ashworth Scale. 5. Individuals scoring 24 and above on the Standardized Mini-Mental Test. Exclusion Criteria: 1. Individuals with severe dystonia. 2. Those with severe soft tissue and/or joint contractures in the upper limbs. 3. Individuals with active reflex sympathetic dystrophy, active arthritis, fractures, circulatory disorders, or bone malignancies in the affected upper limbs. 4. Those with peripheral nerve injuries in the affected upper limb. 5. Individuals with cognitive or behavioral disorders that would hinder participation in the treatment program. 6. Those with aphasia and apraxia at a level that would hinder participation in the treatment program. 7. Individuals allergic to N Cloth and Lycra.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke Stroke patients with hemiplegia or hemiparesis in the chronic stage

Contacts and locations

Locations

  • Kocaeli University

    Kocaeli, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.